United Therapeutics buy Royal Bank of Canada
Start price
07.07.26
/
50%
€493.50
Target price
07.07.27
€615.51
Performance (%)
-6.81%
Price
09:54
€459.90
Summary
This prediction is currently active. With a performance of -6.81%, the BUY prediction for United Therapeutics by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 07.07.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| United Therapeutics | 0.065% |
| iShares Core DAX® | 2.992% |
| iShares Nasdaq 100 | -1.584% |
| iShares Nikkei 225® | -2.254% |
| iShares S&P 500 | -0.009% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics (UTHR) had its price target raised by Royal Bank Of Canada from $701.00 to $704.00. They now have an "outperform" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€485.40
07.05.26
07.05.26
€596.27
07.05.27
07.05.27
-5.25%
09:54
09:54
United Therapeutics
Start price
Target price
Perf. (%)
€426.90
26.02.26
26.02.26
€544.04
26.02.27
26.02.27
7.73%
09:54
09:54
United Therapeutics
Start price
Target price
Perf. (%)
€364.40
26.09.25
26.09.25
€487.63
26.09.26
26.09.26
26.21%
09:54
09:54